Title |
Recurrent respiratory papillomatosis: current and future perspectives
|
---|---|
Published in |
Therapeutics and Clinical Risk Management, May 2015
|
DOI | 10.2147/tcrm.s81825 |
Pubmed ID | |
Authors |
Marco Carifi, Domenico Napolitano, Morando Morandi, Danilo Dall’Olio |
Abstract |
Although recurrent respiratory papillomatosis is a benign disease of the upper aerodigestive tract caused by infection with human papillomavirus, the disease process is unpredictable, ranging from mild disease and spontaneous remission to an aggressive disease with pulmonary spread and requirement for frequent surgical debulking procedures. It can present a protracted clinical course and cause potentially life-threatening compromise of the airways. Over recent decades, a number of alternative medical therapies to standard surgical treatment have been investigated, with modest outcomes overall. Currently, some additional therapies are being explored, together with novel surgical instrumentation that can help to avoid inevitable long-term stenotic complications, ultimately affecting quality of life. Hopefully, clinicians might soon be able to significantly improve the quality of treatment and outcomes for patients affected with recurrent respiratory papillomatosis, with human papillomavirus vaccination having a potentially important role. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 3 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 2 | 67% |
Members of the public | 1 | 33% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | <1% |
Chile | 1 | <1% |
Unknown | 163 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 27 | 16% |
Student > Postgraduate | 22 | 13% |
Student > Master | 15 | 9% |
Student > Doctoral Student | 15 | 9% |
Other | 13 | 8% |
Other | 28 | 17% |
Unknown | 45 | 27% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 80 | 48% |
Immunology and Microbiology | 6 | 4% |
Biochemistry, Genetics and Molecular Biology | 5 | 3% |
Engineering | 5 | 3% |
Nursing and Health Professions | 4 | 2% |
Other | 13 | 8% |
Unknown | 52 | 32% |